With the exception of the Cognition domain that remained stable, these scores also showed a trend of worsening in the 4 months before taking the drug, of improvement during treatment and of subsequent worsening after withdrawal.
← all excerpts
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients.
1
—
—